EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Is Routine Interruption of Direct Oral Anticoagulants Necessary during Colorectal Endoscopic Mucosal Resection and Hot Snare Polypectomy? A Multicenter Propensity‐Matched Study

Yutaka Okagawa, Masanori Sato, Masahiro Hirakawa, Shogo Miura, Naotaka Hayasaka, Yusuke Tomita, Saki Ameda, Ginji Omori, Shutaro Oiwa, Akira Sakurada, Tomoyuki Abe, Shinya Minami und 5 weitere

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70569 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Yutaka Okagawa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Postoperative Hemorrhage, Colonic Polyps, Anticoagulants. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Grant of Japan Gastroenterological Endoscopy Society Hokkaido Chapter.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Colorectal endoscopic mucosal resection (EMR) and hot snare polypectomy (HSP) are high‐bleeding‐risk endoscopic procedures, and most clinical guidelines recommend stopping direct oral anticoagulants (DOACs) temporarily or switching to heparin‐bridging therapy (HBT). However, existing evidence is largely derived from cohorts that combine warfarin and DOAC users or include substantial use of HBT, and data directly comparing the continuation versus interruption of DOACs are limited. We aimed to assess whether periprocedural DOAC interruption reduces delayed postpolypectomy bleeding (DPPB) in patients undergoing EMR/HSP.

Methods

Consecutive patients receiving DOAC therapy who underwent colorectal EMR or HSP between April 2020 and March 2024 were included in this retrospective study. The patients were classified into continuation and interruption groups following periprocedural DOAC management. Propensity score matching (PSM) was conducted using clinically relevant variables. The primary outcome was DPPB within 28 days.

Results

Overall, 691 patients who were receiving DOACs underwent EMR/HSP, and 146 matched pairs were analyzed. After PSM, covariate balance between the groups was improved. DPPB occurred in six patients (4.1%) in the interruption group and three patients (2.1%) in the continuation group ( p = 0.501; absolute risk difference: 2.05% [95% confidence interval, −1.90%–6.01%]). No thromboembolic events were observed.

Conclusions

DOAC continuation may not substantially increase DPPB risk compared with 1‐day DOAC interruption in patients undergoing colorectal EMR/HSP. However, the small number of bleeding events and wide confidence intervals mean that a clinically meaningful difference cannot be excluded. Further prospective studies are needed to determine the optimal periprocedural DOAC management strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionPostoperative HemorrhageColonic PolypsAnticoagulantsGastrointestinal HemorrhageHumansFemaleMaleRetrospective StudiesPropensity ScoreTreatment InterruptionAdministration, OralAgedTime FactorsMiddle AgedAnticoagulation BridgeAged, 80 and overColonoscopyColorectal Surgical Procedures

Stichwörter der Autor:innen

colon polypectomydelayed postpolypectomy bleedingdirect oral anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
  • Department of Gastroenterology, Sapporo Kyoritsu Gorinbashi Hospital, Sapporo, Hokkaido, Japan.
  • Department of Gastroenterology, Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
  • Department of Gastroenterology, Rumoi Municipal Hospital, Rumoi, Hokkaido, Japan.
  • Department of Gastroenterology, Sapporo Kiyota Hospital, Sapporo, Hokkaido, Japan.
  • Department of Gastroenterology, Tonan Hospital, Sapporo, Hokkaido, Japan.

ORCID-Profile: Tetsuya Sumiyoshi, Kohichi Takada

Förderung

  • Research Grant of Japan Gastroenterological Endoscopy Society Hokkaido Chapter

Zitieren

APA

Okagawa, Y., Sato, M., Hirakawa, M., Miura, S., Hayasaka, N., Tomita, Y., Ameda, S., Omori, G., Oiwa, S., Sakurada, A., Abe, T., Minami, S., Sumiyoshi, T., Nagaoka, Y., Hisai, H., Katsuki, S., & Takada, K. (2026). Is Routine Interruption of Direct Oral Anticoagulants Necessary during Colorectal Endoscopic Mucosal Resection and Hot Snare Polypectomy? A Multicenter Propensity‐Matched Study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70569

Vancouver

Okagawa Y, Sato M, Hirakawa M, Miura S, Hayasaka N, Tomita Y, et al. Is Routine Interruption of Direct Oral Anticoagulants Necessary during Colorectal Endoscopic Mucosal Resection and Hot Snare Polypectomy? A Multicenter Propensity‐Matched Study. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70569

BibTeX
@article{Okagawa2026,
  author = {Okagawa, Yutaka and Sato, Masanori and Hirakawa, Masahiro and Miura, Shogo and Hayasaka, Naotaka and Tomita, Yusuke and Ameda, Saki and Omori, Ginji and Oiwa, Shutaro and Sakurada, Akira and Abe, Tomoyuki and Minami, Shinya and Sumiyoshi, Tetsuya and Nagaoka, Yasuhiro and Hisai, Hiroyuki and Katsuki, Shinichi and Takada, Kohichi},
  title = {Is Routine Interruption of Direct Oral Anticoagulants Necessary during Colorectal Endoscopic Mucosal Resection and Hot Snare Polypectomy? A Multicenter Propensity‐Matched Study},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70569}
}
Kostenlos starten →